chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient presented to pharmacy the morning of 8/11/2017 with what appeared to be an infection at the injection site. The red area resembled cellulitis and was approximately 7x5 inches in area. Patient stated this started the day after the vaccination was administered and had gotten worse by the time she reported to the pharmacy. Patient was advised to seek medical attention and was seen on 8/11/17 by a local provider. She was prescribed keflex/claritin/Ibuprofen for a suspected cellulitis/potential allergic reaction/and pain respectively. Patient was provided these prescriptions here at the pharmacy and will follow up with us here if the condition doesn't improve.
angry; terrible cramping in his left calf; not sure if it is soreness or cramp, but it is pretty much painful , "I don´t know if I have a blood clot or something but I am in constant pain"; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (terrible cramping in his left calf), PAIN IN EXTREMITY (not sure if it is soreness or cramp, but it is pretty much painful , "I don´t know if I have a blood clot or something but I am in constant pain") and ANGER (angry) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Apr-2021, the patient experienced MUSCLE SPASMS (terrible cramping in his left calf) and PAIN IN EXTREMITY (not sure if it is soreness or cramp, but it is pretty much painful , "I don´t know if I have a blood clot or something but I am in constant pain"). On an unknown date, the patient experienced ANGER (angry). At the time of the report, MUSCLE SPASMS (terrible cramping in his left calf), PAIN IN EXTREMITY (not sure if it is soreness or cramp, but it is pretty much painful , "I don´t know if I have a blood clot or something but I am in constant pain") and ANGER (angry) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information not provided. List of concomitant medication were not given.
when I arrived home both my cheeks had a speckled rash. - It went away Five days later I started to get red blotches bigger than a quarter on my left neck  7 or 8 total and one each on my arms  . the one on my right arm was a little bit larger than a golf ball. All are raised and very itchy. Have an appointment for tomorrow with dermatologist
Warmth, swelling, pain at the injection site. Per parents happened few hours after injection and thought it was normal. Swelling has increased and presented in office from shoulder down to elbow. Denied fever, shortness of breath.
Guillain Barre Syndrome; body began paralyzing itself; lost his ability to walk; So much suffering and severe nerve pain; Initial information received on 14-Oct-2020 regarding an unsolicited valid serious case from a non-health care professional (patient's wife) via social media .  This case involves a male patient of an unknown age who developed Guillain-Barre syndrome, his body began paralyzing itself (paralysis), lost his ability to walk (gait inability) and severe nerve pain/ so much suffering (neuralgia), while he received vaccine INFLUENZA VACCINE.  At the time of the event, the patient was a compromised sick guy with ongoing dialysis (Crazy blood cleaning treatment) and was suffering so much.  Concomitant medication(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiration date were not reported) via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date , the patient developed serious events of Guillain-Barre syndrome, 3 years ago, his body began paralyzing itself (paralysis) ,lost his ability to walk (gait inability) and severe nerve pain/ so much suffering (neuralgia) (unknown latency) following the administration of INFLUENZA VACCINE. These events were assessed as medically significant.  A patient was seeing  specialists and they started the transplant process over at a better hospital.  No laboratory data reported.  Diagnosis was reported as Guillain-Barre syndrome.  The patient recovered from the event of gait inability on an unknown date, while did not recovered from Guillain Barre syndrome.  The outcome was unknown for the events paralysis and neuralgia.  Information on the batch number to be requested for this case.; Sender's Comments: This case involves male patient of unknown age who presented with Guillain-Barre syndrome, paralysis, gait inability and neuralgia, after vaccination with INFLUENZA VACCINE from unknown manufacturer. Time to onset is unknown. Patient was already on dialysis. Other relevant information regarding patient's condition and lab data excluding other etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of the vaccine cannot be assessed.
Initial misuse report received from a healthcare professional on 05 April 2013. The patient had used Merck diluent to reconstitute ACTHIB. (No information was provided regarding the patient). No adverse event was reported. List of documents held by sender: none.
Arm was red and swollen and very painful for the first 24 hours 72 hours later the swelling and redness has decreased and no more pain.
Adverse Events: Slight Fever, pain at injection site, fatigue, muscle pain Treatment: acetaminophen Outcome: symptoms lasted 4 days
Left-sided facial paralysis. Treated with 7 days of prednisone 60 mg daily and valacyclovir 1 gram TID. As of this date, gradual improvement.
Appendicitis. - J&J vaccine received on Tuesday, 26 October, at a time of 1530. - Friday, 29 October, at a time of 0230 I woke up with severe abdominal pain. - Friday, 29 October, at 1430 I was having emergency surgery to remove my appendix.
7/16/2022 - 7/21/2022 (5 days) HOSPITAL  Patient is a 81 y.o. male who presented to the hospital after not being able to breath at home. The family provided the history as the patient was intubated when I saw him. He was ill since 7/13 with fevers, sweats, chills, malaise, cough and sputum production. The next day he tried to get up from a chair and fell onto his face. He said that his leg was not working when he got up. His family urged him to go to the hospital, but he refused. He went to bed instead and his leg worked normally in the morning. This apparently happens to him at times and he thinks it just "fall asleep in him".    He continued to have worsening cough and shortness of breath. Family tried to get him tested for COVID-19 but he refused and said he did not have the virus. Multiple family members were also sick and were taking allergy medicine to treat it.    Today he was not breathing well so they called the ambulance. In route to the hospital he became unresponsive and had oxygen saturations in the 60s. He had 2 IOs placed in his tibias. He was originally going to different Hospital due to concern of his worsening mental status and his recent fall while on blood thinners. He was then rerouted to this Hospital due to respiratory arrest.    He was intubated in the ER and started to become more responsive and was trying to pull his ETT out. He was placed on propofol and then needed Norepi to support his blood pressure while on sedation. VBG showed hypercapnea which is assume to be the cause of his decreased mentation. CT head was obtained which was unremarkable.   Upon his presentation the patient was immediately intubated for respiratory failure.  Following intubation the patient was placed on sedation.  He was hypotensive and required norepinephrine to maintain blood pressures.  Workup demonstrated COVID infection was suspected superinfection bacterial pneumonia.  The patient was started on steroids, ceftriaxone and azithromycin, and admitted to the intensive care unit.  The patient did well was able to be weaned from his pressor support following day.  Patient was extubated on July 17, 2022. Following extubation he continued to have respiratory failure requiring BiPAP.  At this time he is weaning from his BiPAP while diuresing.  Overall patient is clinically improving with care.
headache; Blood pressure was measured to be 160/90mmHg; This is a spontaneous report from a non-contactable/contactable Pharmacist. A 39-year-old patient of unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Lot Number: EW0187, unspecified expiration date) dose 2, single through intramuscular, administered in left arm on 24Sep2021 10:00am for COVID-19 immunization (Age at vaccination: 39-year-old). The patient was previously vaccinated with BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Lot Number: EW0187, unspecified expiration date) on 03Sep2021 10:00am for COVID-19 immunization with events vials was diluted with 0.18 ml of diluent and slight pain in left arm. The patient had no prior vaccinations. The patient medical history was unknown. Concomitant medications were unknown. On unspecified date, the patient experienced headache and blood pressure was measured to be 160/90 mmHg. The laboratorial test included blood pressure was measured to be 160/90 mmHg. Outcome of all the events was unknown.    No follow up attempts are possible. No further information is expected.
Upon injection, I had an immediate headache, which never let up for 4 days, never responded to repeated ibuprofen doses (6 hrs.+ apart), and was severe enough to keep me awake at night.  By Friday night, my temperature was 100 degrees, and I typically register at 97.0 degrees.  I also had sores on my tongue  and around my mouth, a sore throat that felt like a swollen gland, and my joints were painful throughout my body.  Anywhere I previously felt any pain (such as my arthritic right knee) was somehow triggered by this vaccination.  Fatigue persisted through Sunday (the 4th day).  I didn't have this kind of reaction with my first Shingrix vaccine, nor any other recent vaccine (including COVID vax), so I
Red bumpy itchy rash on both breasts, belly, back, neck and on upper leg; Red bumpy itchy rash on both breasts, belly, back, neck and on upper leg; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Red bumpy itchy rash on both breasts, belly, back, neck and on upper leg) and RASH ERYTHEMATOUS (Red bumpy itchy rash on both breasts, belly, back, neck and on upper leg) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced RASH PRURITIC (Red bumpy itchy rash on both breasts, belly, back, neck and on upper leg) and RASH ERYTHEMATOUS (Red bumpy itchy rash on both breasts, belly, back, neck and on upper leg). At the time of the report, RASH PRURITIC (Red bumpy itchy rash on both breasts, belly, back, neck and on upper leg) and RASH ERYTHEMATOUS (Red bumpy itchy rash on both breasts, belly, back, neck and on upper leg) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.  No treatment details were provided.
Patient experienced redness, swelling, tenderness and pain at the injection site and the surrounding area which also spread around the bicep to the back of the arm. She has been icing and taking tylenol for the pain.
Mother states arrived home @ about 11 am.  Pt. began having reaction starting @ about 11:30 am.  Began with swollen mouth, then right eye, then cheeks and finally entire face.  Denies redness or rash.  Temp 99.9 F.  Given injection by Dr.
High pitched constant tinnitus primarily out of left ear starting about two days after vaccination.  The tinnitus lead to generalized anxiety and difficulty sleeping.  ER prescribed sleeping aide when it first started.  ENT prescribed a round of methylprednisone which did not fix.  Still ongoing and has not resolved.
This case was reported by a other health professional via call center representative and described the occurrence of pain in a adult female patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX with an associated reaction of pain (erythema after 1st dose refer case, US2018160765). On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced pain, rash, feeling of warmth, pruritus and swelling. The patient was treated with Antihistamines. Rechallenge with SHINGRIX was positive. On an unknown date, the outcome of the pain was recovered/resolved and the outcome of the rash was not reported and the outcome of the feeling of warmth, pruritus and swelling were recovering/resolving. It was unknown if the reporter considered the pain, rash, feeling of warmth, pruritus and swelling to be related to SHINGRIX. Additional details were reported as follows: This case was reported by a physician assistant. The age at vaccination was not reported. The healthcare professional stated both doses of SHINGRIX vaccines were administered at two different pharmacies. The healthcare professional treated the patient with antihistamines and the patient was 80 percent better at the reporting time.
At first I got shingles. It was on my right and they popped up and it did not look like a regular rash and was really itchy. I went to my doctor and was diagnosed with them and prescribed an antiviral VALTREX and a steroid cream fluocinonide. After 3 days it wasn't as severely itchy, and by the time I finished the antiviral you could still see legions but not as much. I still have the itch though even though it is a lot more mild. On the 31st of December, I contracted COVID. My symptoms were a sore throat, feeling feverish, congestion, runny nose, cough, headaches, and stiff joints. On January 2nd I called my doctor prescribed me PAXLOVID, which I took for all 5 days, which improved me but did not fully clear me. Then a few days later around the 9th the symptoms bounced back a bit, and the previous shingles started to itch a bit more than usual but not a full flare up.
Patient given Kinrix outside of approved age range.  No side effects reported per Mother. Patient doing well.
Severe fatigue, severe muscle aches, vivid dreams. Tylenol and rest. Much better after 48 hours, but persistent muscle aches.
redness, erythema, tenderness at the site of injection left arm on Augmentin.
in bed for over 12 hours; fever; achy; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (in bed for over 12 hours), PYREXIA (fever) and PAIN (achy) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 841120A) for COVID-19 vaccination.     No relevant medical history reported.  Concomitant products included ZOLPIDEM for an unknown indication.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Mar-2021, the patient experienced HYPERSOMNIA (in bed for over 12 hours), PYREXIA (fever) and PAIN (achy). At the time of the report, HYPERSOMNIA (in bed for over 12 hours), PYREXIA (fever) and PAIN (achy) outcome was unknown. Not Provided          Treatment medication not reported. Action taken with mRNA-1273 was not applicable.
approx 20hr p/vax pt devel vomiting x 2, lethargy (limp), pale & irritability;no fever;
LIMITED LEFT ARM MOBILITY. MOTION RANGE UNABLE TO GO ABOVE HEART LEVEL.
blood sugar has been out of control ranging from 250-300; This is a spontaneous report from a contactable consumer.  A 53-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date not reported), via an unspecified route of administration, on the right arm, on 14Jan2021 at a single dose for Covid-19 immunization. Medical history included type 2 diabetes mellitus from Sep2019 and ongoing. There were no concomitant medications. On 14Jan2021, it was reported that 8-10 hours after getting the vaccine, his blood sugar was out of control ranging from 250-300. On 15Jan2021, he has taken his blood sugar twice at the time of report. He took it when he woke and it was 207. Two hours after eating a light breakfast it was 242. The outcome of the event was not recovered.  Information about lot/batch number has been requested.
This is a prospective pregnancy case. This 32-year-old female subject was enrolled in an open label study titled FLUARIX, FLULAVAL, FLUARIX Quadrivalent, FLULAVAL Quadrivalent Pregnancy Registry: a prospective, exploratory, cohort study to detect and describe any abnormal pregnancy outcomes in women intentionally or unintentionally vaccinated with either FLUARIX or FLUARIX Quadrivalent or FLULAVAL or FLULAVAL Quadrivalent during pregnancy or within 28 days preceding conception. The subject received Flu Seasonal QIV Dresden on 5th November 2014. On 5th November 2014, an unknown time after receiving Flu Seasonal QIV Dresden, the subject developed vaccine exposure during pregnancy (Non-serious). The outcome of vaccine exposure during pregnancy was unknown. The pregnancy was ongoing.   Additional details provided: Nurse reported that, she did not know EDD or gestational age. This was 1 of the 2 reports received from the same reporter.
Incorrect vaccine for age--patient was given first dose Moderna on 2/28, so was given second dose Moderna on 4/17 as per CDC guidance.  No AE.
Fever injection site soreness 48 hours. chills, fever and fatique 24hrs. Narrative:
shooting pain; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient.  A 66-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 17Apr2021 at 09:30 as dose 1, single (Lot number: FW0171), in left arm and on 08May2021 at 10:00 as dose 2, single (Lot number: FW0182) at the age of 65 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "arthritis" (unspecified if ongoing); "Dust" (unspecified if ongoing); "mold" (unspecified if ongoing); "some trees" (unspecified if ongoing). Concomitant medication(s) included: LOSARTAN; HCTZ; CALCIUM + VIT D. The following information was reported: PAIN (non-serious), outcome "not recovered", described as "shooting pain". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pain.  Additional information: Facility type vaccine was Pharmacy or Drug Store. Patient did not receive any other vaccine other vaccine in four weeks. Patient did not have covid covid prior vaccination. Other medication in two weeks was Multivitamin. Clinical course: It was reported that 3 days after patient first injection, she started to experience a shooting pain on 20Apr2021 in her left arm from injection site to the elbow, noted mostly when swallowed foods. She had second injection 3 weeks after first one. This pain started in her right arm also a few weeks after, but not as regularly. She continues to experience this 1 year later. She has not taken any boosters due to this problem. Her primary care was notified of this but had since left the practice and she is starting over with her partner at the end of May.
pt recv vax 25OCT95 & parent brought pt to ER w/fever on 26OCT95;discharge dx fever rxn to immunization
Arm pain. Fever. Cough. Weakness. Two ER visits with chest pain left arm pain weakness in legs severe headache
I developed a moderately tender, golf-ball sized left axillary lymph node starting 48 hours after the vaccine, peaking around 72 hours, and lasting until 7 days after the vaccine. The degree of tenderness (3/10 at rest, 6/10 with manipulation) precluded tight clothing and laying on the left side of my body but was tolerable. I monitored it myself and it resolved spontaneously. There was no other LAD noted. I know LAD is one of the known side effects, but I thought this might be a more severe case than usual.
High fever during the night, arose from bed to go to bathroom and passed out (synoptic event). Was taken to the hospital in locally.  Fractured arm in fall.  was discharged a few hours later with no further symptoms (fever, aches) other than fractured arm.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 17Nov2021 at 14:30 as dose 3 (booster), single (Lot number: 301558A) at the age of 40 years, in right arm for covid-19 immunization; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunization. The patient had no relevant medical history. The patient had no known allergies. There were no concomitant medications. Other medications in two weeks reported as no. The patient was not pregnant at the time of vaccination. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of covid-19. Clinical course: Therapeutic measures included Anti-viral details: Product: COVID 19 Treatment, Brand: Paxlovid, treatment started on 29Sep2022 and stopped on 29Sep2022, Lot number: GF1750, Indication: Treatment of Covid-19.  No follow-up attempts are possible. No further information is expected.
Polyarthralgias located in left arm (injection site), lumbar-sacral spinal area, bilateral thigh area and  bilateral leg area. Polyarthralgias still ongoing 5 months after injection.
Fever; Rash; Swelling; Aches and pain; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), RASH (Rash), SWELLING (Swelling) and PAIN (Aches and pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced PYREXIA (Fever), RASH (Rash), SWELLING (Swelling) and PAIN (Aches and pain). At the time of the report, PYREXIA (Fever), RASH (Rash), SWELLING (Swelling) and PAIN (Aches and pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Information has been received from a physician concerning his son, who was vaccinated "many years ago" with MMR II. Subsequently the patient experienced mumps and swelling of the neck glands. No further information is available.